Malignancy: Clinical Trials

5 trials for Malignancy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 2, 3 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Unknown 5
Phase 33Unknown 3
Phase 11Unknown 1

Follow Malignancy: new trials by email Literature Review of Malignancy trials Research Report on Malignancy

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated Proteins
Al18F-NOTA-FAPI - Malignancy
Phase 2 / Phase 3UnknownCancer Institute and Hospital, Chinese Academy of Medical Sciences5002023-01-082024-03-29
Treatment of Malignant Tumors With NK Cell
Decitabine combined with NK cell infusion - Malignancy
Phase 1 / Phase 2UnknownShenzhen University General Hospital602021-02-052021-12-03
Real-time Cancer Pain Assessment and Intervention
real-time monitoring and instruction of cancer pain, standard cancer pain care - Malignancy, Pain
Phase 2 / Phase 3UnknownSun Yat-sen University2002012-03-012015-08-27
CO(Mbined Therapy of Malignant) S(Alivary Gland tu)M(Ours With)I(MRT and) c(Arbon Ions): COSMIC
carbon ion boost - Malignancy, Salivary Glands
Phase 2UnknownHeidelberg University542010-06-012013-04-24
Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)
Levofloxacin - Malignancy, Allogeneic Stem Cell Transplantation
Phase 2 / Phase 3UnknownCharite University, Berlin, Germany2007-11-30

Narrower conditions

Neoplasms (5)  ·  Cancer Pain (1)  ·  Pain (1)

Broader conditions

Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Levofloxacin (1)

Sponsors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)  ·  Charite University, Berlin, Germany (1)  ·  Heidelberg University (1)  ·  Shenzhen University General Hospital (1)  ·  Sun Yat-sen University (1)

Countries

China (3)  ·  Germany (2)

Top investigators

Igor Wolfgang Blau, Dr. (1)  ·  Li Yu, Dr (1)  ·  Li Zhang, professor (1)  ·  Marc W Muenter, MD (1)  ·  Rong Zheng, M.D. (1)

Results publications

PMID 20937120, PMID 22551422